CURE.ASX
Global X S&P Biotech ETF
https://www.marketindex.com.au/asx/cure/financials
Annual Financial Summary
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
N/A
N/A
N/A
N/A
Profitability
NPAT ($)
4,073,000
6,785,000
-
-
-
-
NPAT Margin
--
--
-
-
-
-
Abnormals ($)
-
-
-
-
-
-
NPAT before Abnormals ($)
4,073,000
6,785,000
-
-
-
-
Return on Equity (ROE)
10.42%
17.15%
-
-
-
-
Return on Assets (ROA)
10.42%
17.15%
-
-
-
-
Valuation
PE Ratio
9.69
5.85
-
-
-
-
PE Relative to Market
61.5%
40.6%
-
-
-
-
Price to Book
1.01
1.00
-
-
-
-
Price to Cash Flow
13.85
8.36
-
-
-
-
Shares Outstanding (M)
0.82
0.92
-
-
-
-
Market Cap ($M)
$39.49
$39.70
-
-
-
-
Enterprise Value ($M)
$39.44
$39.65
-
-
-
-
Performance
Total Shareholder Return
11.5%
16.6%
-
-
-
-
Relative to Market
-1.0%
1.8%
-
-
-
-
Per Share
Earnings (EPS Adjusted)
494.30
734.31
-
-
-
-
Earnings (with Abnormals)
494.30
734.31
-
-
-
-
Cash Flow
556.30
975.00
-
-
-
-
Cash
0.06
0.05
-
-
-
-
Net Tangible Assets
47.42
42.81
-
-
-
-
Book Value
47.42
42.81
-
-
-
-
Share Price
$47.92
$42.96
-
-
-
-
Liquidity
Quick Ratio
5.67
3.47
-
-
-
-
Current Ratio
5.67
3.47
-
-
-
-
Efficiency
Asset Turnover
0.00
0.00
-
-
-
-
Inventory Turnover
-
-
-
-
-
-
Working Capital Turnover
0.00
0.00
-
-
-
-
Dividends
DPS (c)
-
-
-
-
-
-
Dividend yield
-
-
-
-
-
-
Franking
-
-
-
-
-
-
Gross DPS (c)
-
-
-
-
-
-
Gross Dividend Yield
-
-
-
-
-
-
Payout Ratio
-
-
-
-
-
-
Member Content
Source:
Annual Financial Income Statement
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
N/A
N/A
N/A
N/A
Revenue from Operations
Investment Income
2,022,000
(5,448,000)
-
-
-
-
Other Income
122,000
2,000
-
-
-
-
Expenses
(201,000)
(225,000)
-
-
-
-
Profit / Loss before income tax
4,073,000
6,785,000
-
-
-
-
Tax Expense
-
-
-
-
-
-
NPAT before Abnormals
4,073,000
6,785,000
-
-
-
-
Abnormals
-
-
-
-
-
-
Abnormals Tax
-
-
-
-
-
-
Net Abnormals
-
-
-
-
-
-
Outside Equity
-
-
-
-
-
-
Preference Dividends
-
-
-
-
-
-
Reported NPAT after Abnormals
4,073,000
6,785,000
-
-
-
-
EQUITY
Share End
824,000
924,000
-
-
-
-
Share Weighted
824,000
924,000
-
-
-
-
Ordinary Dividends
-
-
-
-
-
-
EPS Adjusted
4,943,000
7,343,100
-
-
-
-
EPS after Abs
4,942,961
7,343,074
-
-
-
-
Equity Profit / Loss
-
-
-
-
-
-
Member Content
Source:
Annual Financial Balance Sheet
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
N/A
N/A
N/A
N/A
CURRENT ASSETS
Cash and Cash Equivalents
0.05
0.04
-
-
-
-
Receivables
0.03
0.02
-
-
-
-
Investments
-
-
-
-
-
-
Other Current Assets
-
-
-
-
-
-
Total Current Assets
0.08
0.06
-
-
-
-
NON-CURRENT ASSETS
Investments
39.01
39.52
-
-
-
-
Property
-
-
-
-
-
-
Other Non-Current Assets
-
-
-
-
-
-
Total Non-Current Assets
39.01
39.52
-
-
-
-
TOTAL ASSETS
39.09
39.57
-
-
-
-
CURRENT LIABILITIES
Creditors
0.01
0.02
-
-
-
-
Provisions
-
-
-
-
-
-
Other Liabilities
-
-
-
-
-
-
TOTAL CURRENT LIABILITIES
0.01
0.02
-
-
-
-
NON-CURRENT LIABILITIES
Borrowings
-
-
-
-
-
-
Deferred Tax
-
-
-
-
-
-
Other Non-Current Liabilities
-
-
-
-
-
-
TOTAL NON-CURRENT LIABILITIES
-
-
-
-
-
-
TOTAL LIABILITIES
0.01
0.02
-
-
-
-
NET ASSETS
39.1
39.59
-
-
-
-
Total Equity Attr. to Holders
39.08
39.56
-
-
-
-
Outside Equity
-
-
-
-
-
-
TOTAL EQUITY
39.08
39.56
-
-
-
-
Member Content
Source:
Annual Financial Cash Flow
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
N/A
N/A
N/A
N/A
CASH FLOWS FROM OPERATING ACTIVITIES
Receipts
59.16
39.93
-
-
-
-
Payments
(54.71)
(30.95)
-
-
-
-
Funds from Operations
-
-
-
-
-
-
Dividends Received
0.04
0.04
-
-
-
-
Interest Received
-
-
-
-
-
-
Interest Paid
-
-
-
-
-
-
Tax Paid
-
-
-
-
-
-
Other Operating Cash
0.09
(0.02)
-
-
-
-
NET CASH FROM OPERATING ACTIVITIES
4.58
9.01
-
-
-
-
CASH FLOWS FROM INVESTING ACTIVITIES
Receipts
-
-
-
-
-
-
Payments
-
-
-
-
-
-
PP&E
-
-
-
-
-
-
Proceeds PP&E
-
-
-
-
-
-
Purchase Subsidiary
-
-
-
-
-
-
Proceeds Subsidiary
-
-
-
-
-
-
Loans Granted
-
-
-
-
-
-
Loans Repaid
-
-
-
-
-
-
Other Investing Cash
-
-
-
-
-
-
NET CASH FROM INVESTING ACTIVITIES
-
-
-
-
-
-
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issue
0.78
1.68
-
-
-
-
Proceeds from Borrowings
-
-
-
-
-
-
Borrowings
-
-
-
-
-
-
Dividends Paid
-
(0.02)
-
-
-
-
Other Financing Cash
(5.33)
(10.79)
-
-
-
-
NET CASH FROM FINANCING ACTIVITIES
(4.55)
(9.13)
-
-
-
-
NET CHANGE IN CASH
0.03
(0.12)
-
-
-
-
CASH AT START
0.04
0.08
-
-
-
-
Exchange Rate Adjustment
(0.02)
0.09
-
-
-
-
Other Cash Adjustment
-
-
-
-
-
-
CASH AT END
0.05
0.04
-
-
-
-
Member Content
Source: